About

Edwin L. Miller Jr. has practiced corporate and securities law for over 40 years. He has represented both issuers and underwriters in scores of IPOs, secondary stock offerings and other public market transactions that have raised billions of dollars. Edwin has also represented venture capital firms and technology companies in venture financings throughout his time in practice.

More recently, he has concentrated on the representation of emerging technology companies, including completing a number of recent IPOs. For example, he has advised on more than 100 issuer-side and underwriter-side IPOs and other public financings. Recent issuer-side IPOs include Mazor Robotics (surgical device); Alcobra Ltd. (ADHD drug development); Bio Blast Pharma; and several companies currently in registration.

In addition, he has extensive experience in representing both acquirers and sellers in mergers and acquisitions. For example, on the seller-side, these include: X-Café LLC (coffee extracts) to Kerry (Ireland) ($30 million); Ibrix (file serving software) to Hewlett-Packard (price undisclosed); SMaL Camera Technologies to Cypress Semiconductor ($40+ million); Ciphent Inc. (internet security software and services) to Accuvant (price undisclosed); and Cambridge Analog Technologies (semiconductors) to Maxim Integrated Products (price undisclosed). On the buyer-side, M&A transactions include: the purchase by Iron Mountain of Connected Corporation ($120 million), LiveVault ($50 million), Stratify ($160 million) and Mimosa Systems ($110 million); the acquisition/spinoff of Travel Centers of America by Hospitality Properties Trust ($2 billion); the purchase by Taconic Farms of the Xenogen Biosciences division of Caliper Life Sciences; and the purchase by Konarka Technologies of Siemens’ photovoltaics business in Germany.

An extensive roster comprises, for example, American DG Energy (co-generation); Charles River Analytics (advanced government research); Evologie (skin care); Ferric Inc. (semiconductors); Natel Energy (low-head hydro technology); Pillar Investments (Beirut) (investment banking); Playsquare (interactive entertainment software); Pluristem Therapeutics (Haifa) (stem cells); PolyPid (Israel) (drug delivery); Silenseed (Israel) (cancer therapeutics); Tecogen (co-generation); and Rosse Enterprises (private investments).

Representative Client Work

  • Over 100 other issuer-side and underwriter-side IPOs and other public financings. Recent issuer-side IPOs include Mazor Robotics (surgical device); Alcobra Ltd. (ADHD drug development); Bio Blast Pharma; and several companies currently in registration
  • Sell-side M&A transactions include X-Café LLC (coffee extracts) to Kerry (Ireland) ($30 million); Ibrix (file serving software) to Hewlett-Packard (price undisclosed); SMaL Camera Technologies to Cypress Semiconductor ($40+ million); Ciphent Inc. (internet security software and services) to Accuvant (price undisclosed); and Cambridge Analog Technologies (semiconductors) to Maxim Integrated Products (price undisclosed)
  • Buy-side M&A transactions include the purchase by Iron Mountain of Connected Corporation ($120 million), LiveVault ($50 million), Stratify ($160 million) and Mimosa Systems ($110 million); the acquisition/spinoff of Travel Centers of America by Hospitality Properties Trust ($2 billion); the purchase by Taconic Farms of the Xenogen Biosciences division of Caliper Life Sciences; and the purchase by Konarka Technologies of Siemens’ photovoltaics business in Germany
  • Representative clients: American DG Energy (co-generation); Charles River Analytics (advanced government research); Evologie (skin care); Ferric Inc. (semiconductors); Natel Energy (low-head hydro technology); Pillar Investments (Beirut) (investment banking); Playsquare (interactive entertainment software); Pluristem Therapeutics (Haifa) (stem cells); PolyPid (Israel) (drug delivery); Silenseed (Israel) (cancer therapeutics); Tecogen (co-generation); and Rosse Enterprises (private investments)